Ownership
Private
Employees
~100
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved

IXOPAY General Information

IXOPAY provides an enterprise-grade payment orchestration platform that enables businesses to manage payments across multiple providers with features like tokenization, card lifecycle management, and compliance modules. It serves over 700 customers globally and processes $40 billion in payments annually. The company merged with TokenEx in April 2024 to enhance its data security and vaulting capabilities.

Contact Information

Primary Industry
Biomedical IT and Biomedical Data Platforms
Corporate Office
Vienna, Vienna
Austria

Drug Pipeline

No pipeline data available

For full access to IXOPAY's pipeline data

Book a demo

Key Partnerships

Paysafe, Paydoo, Vyne, Fraudio, Payaut, Fraugster

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

IXOPAY Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view IXOPAY's complete valuation and funding history, request access »

IXOPAY Financial Metrics